Lawrence O. Gostin

4

Articles

0

Comments
  • University Professor; Founding Linda D. & Timothy J. O’Neill Professor of Global Health Law, Georgetown University
Kruish Mubiru, executive director of an HIV/Aids NGO in Uganda, in its empty facilities in Kampala. The Pepfar fund cuts have crippled the organisation. Getty Images

Pepfar funding to fight HIV/Aids has saved 26 million lives since 2003: how cutting it will hurt Africa

Eric Friedman, Georgetown University; Lawrence O. Gostin, Georgetown University, and Sarah Wetter, Georgetown University

Pepfar, a global initiative to fight HIV/Aids, has saved millions of lives since its launch in 2003. Now its future is uncertain.
The increasingly well-coordinated global anti-vaccine movement has repurposed itself to challenge the very reality of COVID-19. Hasan Esen/Anadolu Agency via Getty Images

COVID‑19: A global survey shows worrying signs of vaccine hesitancy

Scott C. Ratzan, CUNY Graduate Center; Agnes Binagwaho, University of Global Health Equity; Heidi Larson, London School of Hygiene & Tropical Medicine; Jeffrey V Lazarus, Barcelona Institute for Global Health (ISGlobal); Kenneth Rabin, CUNY Graduate Center, and Lawrence O. Gostin, Georgetown University

A safe, effective COVID-19 vaccine is expected to be developed in record time and may be approved for production, distribution and acceptance some time in 2021.

Contact Lawrence for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision